IMPRO PRECISION (01286) Considers Separate Listing for Aviation, Energy, and Medical Divisions

Stock News
Mar 11

IMPRO PRECISION (01286) announced its annual results for 2025 on March 10. Revenue reached HKD 5.096 billion, representing a year-on-year increase of 8.7%. Profit attributable to shareholders was HKD 726 million, up 12.7% year-on-year, while adjusted profit attributable to shareholders was HKD 689 million, a 12.1% increase, both setting new historical highs.

Simultaneously, IMPRO PRECISION mentioned in its results announcement that the Group is continuously evaluating a potential separate listing for its Aviation, Energy, and Medical end-market segments, alongside other viable financing options. This strategy aims to support future expansion of production capacity and process capabilities and to make forward-looking arrangements for the long-term sustainable development of the Aviation segment.

The results announcement stated that during the year, the strong momentum in artificial intelligence continued to drive growth in related data center demand. High-horsepower engines, as key components for distributed generators, saw a significant rise in demand, leading to a 43.3% year-on-year surge in sales for the Group's high-horsepower engine end-market. Furthermore, demand for liquid cooling systems related to AI data centers was also very robust, contributing to a 38.4% year-on-year increase in revenue from the Diversified Industrial - Other end-market.

Additionally, as new products entered mass production, revenue from the Medical end-market rose substantially by 55.2% compared to the previous year.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10